Researchers are the first to create sensory interneurons from stem cells
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have, for the first time, coaxed human stem cells to become sensory interneurons — the cells that give us our sense of touch. The new protocol could be a step toward stem cell–based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.
The study, which was led by Samantha Butler, a UCLA associate professor of neurobiology and member of the Broad Stem Cell Research Center, was published today in the journal Stem Cell Reports.
Sensory interneurons, a class of neurons in the spinal cord, are responsible for relaying information from throughout the body to the central nervous system, which enables the sense of touch. The lack of a sense of touch greatly affects people who are paralyzed. For example, they often cannot feel the touch of another person, and the inability to feel pain leaves them susceptible to burns from inadvertent contact with a hot surface.
“The field has for a long time focused on making people walk again,” said Butler, the study’s senior author. “‘Making people feel again doesn’t have quite the same ring. But to walk, you need to be able to feel and to sense your body in space; the two processes really go hand in glove.”
In a separate study, published in September by the journal eLife, Butler and her colleagues discovered how signals from a family of proteins called bone morphogenetic proteins, or BMPs, influence the development of sensory interneurons in chicken embryos. The Stem Cell Reports research applies those findings to human stem cells in the lab.
When the researchers added a specific bone morphogenetic protein called BMP4, as well as another signaling molecule called retinoic acid, to human embryonic stem cells, they got a mixture of two types of sensory interneurons. DI1 sensory interneurons give people proprioception — a sense of where their body is in space — and dI3 sensory interneurons enable them to feel a sense of pressure.
The researchers found the identical mixture of sensory interneurons developed when they added the same signaling molecules to induced pluripotent stem cells, which are produced by reprogramming a patient’s own mature cells such as skin cells. This reprogramming method creates stem cells that can create any cell type while also maintaining the genetic code of the person they originated from. The ability to create sensory interneurons with a patient’s own reprogrammed cells holds significant potential for the creation of a cell-based treatment that restores the sense of touch without immune suppression.
Butler hopes to be able to create one type of interneuron at a time, which would make it easier to define the separate roles of each cell type and allow scientists to start the process of using these cells in clinical applications for people who are paralyzed. However, her research group has not yet identified how to make stem cells yield entirely dI1 or entirely dI3 cells — perhaps because another signaling pathway is involved, she said.
The researchers also have yet to determine the specific recipe of growth factors that would coax stem cells to create other types of sensory interneurons.
The group is currently implanting the new dI1 and dI3 sensory interneurons into the spinal cords of mice to understand whether the cells integrate into the nervous system and become fully functional. This is a critical step toward defining the clinical potential of the cells.
“This is a long path,” Butler said. “We haven’t solved how to restore touch but we’ve made a major first step by working out some of these protocols to create sensory interneurons.”
The Latest on: Stem cell–based therapies
- New gene therapy via skin can combat cocaine addiction on September 18, 2018 at 11:47 am
Scientists have developed a novel approach using skin cell-based gene therapy to stifle the ... The study showed that epidermal stem cells "can be successfully employed for ex vivo gene therapy, as ef... […]
- Major Stem Cell Breakthroughs Giving Investors Big Opportunity on September 18, 2018 at 10:24 am
$1.68 BioRestorative Therapies, Inc. (BRTX), a life sciences company focused on stem cell-based therapies, just announced that the Journal of Translational Medicine has published the results of the Co... […]
- Addicted to cocaine? This new gene therapy may help you overcome on September 18, 2018 at 9:12 am
This skin cell-based therapy can restrain your desire for cocaine and prevent ... The study involved collection of primary epidermal basal progenitor or stem cells from new born mice. The researchers ... […]
- Baby tooth stem cells could regrow kids' dental tissue on September 17, 2018 at 10:31 pm
The stem cell-based treatment produced all the necessary ingredients for tissue, and there weren't any worries about immune system rejection. Patients who went through conventional treatment (which on... […]
- CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy on September 17, 2018 at 8:30 am
ViaCyte’s attempts to develop a stem cell therapy for diabetes have been stymied by the immune system, which recognizes the implanted cells as foreign. Meanwhile, CRISPR Therapeutics has found success ... […]
- 2D material produces highest ever signals for human embryonic stem cell detection on September 16, 2018 at 11:47 pm
The future of electrical-based detection systems This research will be critical to the development of human embryonic stem cell-based therapy, the researchers say. "Not only can we ensure the safety o... […]
- Opinion | The importance of trials in stem cell drugs on September 12, 2018 at 10:35 pm
According to a 2016 article in Stem Cell Research & Therapy , about 1,000 clinical trials using stem cells have been performed globally to date, and more than 10 stem cell-based products have been app... […]
- A starring role for nonhuman primates in the stem cell story on September 11, 2018 at 6:24 am
“It is really the clinical, imaging, and histological outcomes in the NHP model of Parkinson’s disease that convinced me that stem cell-based therapy for neurological conditions will most likely work ... […]
- Norton offers stem cell treatment to help leukemia patients avoid potentially deadly infections on September 11, 2018 at 4:54 am
Some leukemia patients at Norton Healthcare whose immune systems are weakened by chemotherapy now have access to a new stem cell-based treatment that researchers hope will prevent potentially ... […]
- Stem Cell Therapy Market worth $ 145.8 Million by 2021 on September 9, 2018 at 12:33 am
... segment is expected to command the largest share of the global stem cell therapy market in 2016. This large share can be attributed to the rising availability of stem cell-based products for the t... […]
via Google News and Bing News